Home

partea de jos Validare agendă dm1 gene inginer nisipos Împotriva voinței

Steinert's myotonic dystrophy - Symptoms, diagnosis and treatment
Steinert's myotonic dystrophy - Symptoms, diagnosis and treatment

Figure 1 from Myotonic Dystrophy Type 1 (DM1): From the Genetics to Molecular Mechanisms | Semantic Scholar
Figure 1 from Myotonic Dystrophy Type 1 (DM1): From the Genetics to Molecular Mechanisms | Semantic Scholar

Molecular genetics of congenital myotonic dystrophy - ScienceDirect
Molecular genetics of congenital myotonic dystrophy - ScienceDirect

Epigenetics and Myotonic Dystrophy Type 1 | Encyclopedia MDPI
Epigenetics and Myotonic Dystrophy Type 1 | Encyclopedia MDPI

Novel mouse model of myotonic dystrophy displays reversible cardiac disease features of the condition
Novel mouse model of myotonic dystrophy displays reversible cardiac disease features of the condition

RNA toxicity model for DM1 pathogenesis and potential therapeutic... | Download Scientific Diagram
RNA toxicity model for DM1 pathogenesis and potential therapeutic... | Download Scientific Diagram

Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1: Molecular Therapy
Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1: Molecular Therapy

Entrada Therapeutics | Myotonic Dystrophy Type 1 (DM1)
Entrada Therapeutics | Myotonic Dystrophy Type 1 (DM1)

Projects
Projects

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1 | Gene Therapy
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1 | Gene Therapy

DM1 pathogenetic mechanisms and therapeutic strategies. The actions of... | Download Scientific Diagram
DM1 pathogenetic mechanisms and therapeutic strategies. The actions of... | Download Scientific Diagram

Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions
Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions

RNA toxic gain-of-function model for DM1 pathogenesis. Mutant DMPK RNA... | Download Scientific Diagram
RNA toxic gain-of-function model for DM1 pathogenesis. Mutant DMPK RNA... | Download Scientific Diagram

Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics - Chau - 2015 - Developmental Dynamics - Wiley Online Library
Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics - Chau - 2015 - Developmental Dynamics - Wiley Online Library

Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene: Molecular Therapy - Nucleic Acids
Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene: Molecular Therapy - Nucleic Acids

Ligand for Potential Treatment of Myotonic Dystrophy Type 1 (DM1) | UIUC Office of Technology Management
Ligand for Potential Treatment of Myotonic Dystrophy Type 1 (DM1) | UIUC Office of Technology Management

Myopathies without EOM Weakness: Facioscapulohumeral + Myotonic Dystrophy
Myopathies without EOM Weakness: Facioscapulohumeral + Myotonic Dystrophy

Frontiers | Muscle wasting in myotonic dystrophies: a model of premature aging
Frontiers | Muscle wasting in myotonic dystrophies: a model of premature aging

Myotonic dystrophy: Emerging mechanisms for DM1 and DM2 - ScienceDirect
Myotonic dystrophy: Emerging mechanisms for DM1 and DM2 - ScienceDirect

IJMS | Free Full-Text | Disrupting the Molecular Pathway in Myotonic Dystrophy
IJMS | Free Full-Text | Disrupting the Molecular Pathway in Myotonic Dystrophy

New myotonic dystrophy type 1 mouse model | Cell Research
New myotonic dystrophy type 1 mouse model | Cell Research

IJMS | Free Full-Text | Epigenetics of Myotonic Dystrophies: A Minireview
IJMS | Free Full-Text | Epigenetics of Myotonic Dystrophies: A Minireview

Cardiovascular manifestations of Myotonic Dystrophy
Cardiovascular manifestations of Myotonic Dystrophy

DM1-AS Gene - GeneCards | DM1-AS RNA Gene
DM1-AS Gene - GeneCards | DM1-AS RNA Gene

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2 | European Journal of Human Genetics
Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2 | European Journal of Human Genetics

Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells: Molecular Therapy - Nucleic Acids
Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells: Molecular Therapy - Nucleic Acids